Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| ISRCTN85456814 |
Not provided
Not provided
Not provided
Discontinued cystitis study due to poor recruitment. To continue the trial under these circumstances is considered non-viable.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The principle objective of this research is to more precisely determine the degree of benefit that hyperbaric oxygen therapy affords in the treatment of late radiation tissue injury.
The study has eight* components. Seven involve the evaluation of established radionecrosis at varying anatomic sites (mandible, larynx, skin, bladder, rectum, colon, and gyn). The eighth will investigate the potential of hyperbaric oxygen (HBO) therapy to prophylax against late radiation tissue injury.
*(One of the arms, HORTIS IV - Proctitis has been closed to further patient recruitment. This decision was based on an interim statistical analysis which generated sufficient evidence to support closing down this arm of HORTIS.)
Radiation therapy is a key component of the control and eradication of malignant disease. Adequate tumoricidal doses may, however, result in damage to surrounding healthy tissue. Therapeutic radiation injuries to non-target tissues can be divided into acute, sub-acute, and delayed complications. Acute injuries are considered a direct cellular toxicity, self-limiting, and in most cases successfully managed symptomatically. Sub-acute injuries are typically identifiable in only a few organ systems, e.g., radiation pneumonitis. These, too, are generally limited but occasionally evolve to late complications. Late changes occur several months to many years after completing radiotherapy.
The etiology of radiation's late effects to normal tissue (LENT) varies somewhat between organ systems. Its hallmark, however, is one of culminating in an obliterative endarteritis, and local hypoxia.
The incidence of LENT is related to both total radiation exposure and the length of time a patient is out from completing radiotherapy. The higher the dose, the longer the interval from exposure, the greater the risk. In many cases, resulting radionecrotic lesions seriously impair form and function, and require extensive surgical correction or repair. Such surgery is fraught with complications, hence the inclusion of a "prophylactic" hyperbaric oxygen arm. A disturbing degree of mortality further complicates the development of LENT.
Hyperbaric oxygen has been utilized in the treatment of radiation tissue injury for several decades. Most of the supportive basic science and clinical evidence stems from the management of mandibular osteoradionecrosis. More recently, the use of hyperbaric oxygen has been extended to other anatomic sites. This expanded use is based, in large part, on a presumed common underlying pathophysiology of LENT, regardless of its anatomic location. Supportive clinical evidence for these other sites is limited, however, and in need of a greater degree of scientific scrutiny.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| A | Active Comparator | Hyperbaric Oxygen Therapy |
|
| B | Sham Comparator | Normal Air |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Hyperbaric Oxygen Therapy | Procedure | HBO at 2.0 ATA |
| |
| Sham treatment |
| Measure | Description | Time Frame |
|---|---|---|
| SOMA (Subjective, Objective, Management, Analytic) scale used to determine late effects to normal tissue (LENT) score | pre-treatment, post-treatment (HBO and placebo) and at follow ups at 3 months, 6 months, and 1 year through 5 years |
| Measure | Description | Time Frame |
|---|---|---|
| Clinical assessment using one of the following criteria: | post-treatment (HBO and placebo) and at follow ups at 3 months, 6 months, and 1 year through 5 years | |
| Healed | post-treatment (HBO and placebo) and at follow ups at 3 months, 6 months, and 1 year through 5 years |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Dick Clarke, CHT | National Baromedical Services | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Palmetto Health Richland | Columbia | South Carolina | 29203 | United States | ||
| Wesley Medical Center |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 9191633 | Background | Curi MM, Dib LL. Osteoradionecrosis of the jaws: a retrospective study of the background factors and treatment in 104 cases. J Oral Maxillofac Surg. 1997 Jun;55(6):540-4; discussion 545-6. doi: 10.1016/s0278-2391(97)90478-x. | |
| 4703530 | Background | Joseph DL, Shumrick DL. Risks of head and neck surgery in previously irradiated patients. Arch Otolaryngol. 1973 May;97(5):381-4. doi: 10.1001/archotol.1973.00780010393005. No abstract available. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Procedure |
Normal air under pressure (1.1 ATA) |
|
| Modestly improved (< 50% lesion resolution) | post-treatment (HBO and placebo) and at follow ups at 3 months, 6 months, and 1 year through 5 years |
| Not improved | post-treatment (HBO and placebo) and at follow ups at 3 months, 6 months, and 1 year through 5 years |
| Other (e.g. lesion recurrence, lesion size progression) | post-treatment (HBO and placebo) and at follow ups at 3 months, 6 months, and 1 year through 5 years |
| Significant Improvement (>50% lesion resolution) | post-treatment (HBO and placebo) and at follow ups at 3 months, 6 months, and 1 year through 5 years |
| Brisbane |
| Queensland |
| 4064 |
| Australia |
| Royal Hobart Hospital | Hobart | Tasmania | 7001 | Australia |
| Instituto Nacional de Cancerologica | Mexico City | 14080 | Mexico |
| University of Stellenbosch | Cape Town | South Africa |
| University of Pretoria Medical Center | Pretoria | 0001 | South Africa |
| Istanbul University Medical Center | Istanbul | 34390 | Turkey (Türkiye) |
| 8285524 | Background | Samuels L, Granick MS, Ramasastry S, Solomon MP, Hurwitz D. Reconstruction of radiation-induced chest wall lesions. Ann Plast Surg. 1993 Nov;31(5):399-405. doi: 10.1097/00000637-199311000-00003. |
| 949677 | Background | Hart GB, Mainous EG. The treatment of radiation necrosis with hyperbaric oxygen (OHP). Cancer. 1976 Jun;37(6):2580-5. doi: 10.1002/1097-0142(197606)37:63.0.co;2-h. |
| 6572704 | Background | Marx RE. Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg. 1983 May;41(5):283-8. doi: 10.1016/0278-2391(83)90294-x. |
| 6574217 | Background | Marx RE. A new concept in the treatment of osteoradionecrosis. J Oral Maxillofac Surg. 1983 Jun;41(6):351-7. doi: 10.1016/s0278-2391(83)80005-6. No abstract available. |
| 7674746 | Background | Bevers RF, Bakker DJ, Kurth KH. Hyperbaric oxygen treatment for haemorrhagic radiation cystitis. Lancet. 1995 Sep 23;346(8978):803-5. doi: 10.1016/s0140-6736(95)91620-2. |
| 9231688 | Background | Woo TC, Joseph D, Oxer H. Hyperbaric oxygen treatment for radiation proctitis. Int J Radiat Oncol Biol Phys. 1997 Jun 1;38(3):619-22. doi: 10.1016/s0360-3016(97)00017-5. |
| 1497044 | Background | Williams JA Jr, Clarke D, Dennis WA, Dennis EJ 3rd, Smith ST. The treatment of pelvic soft tissue radiation necrosis with hyperbaric oxygen. Am J Obstet Gynecol. 1992 Aug;167(2):412-5; discussion 415-6. doi: 10.1016/s0002-9378(11)91421-5. |
| 8286987 | Background | Feldmeier JJ, Heimbach RD, Davolt DA, Brakora MJ. Hyperbaric oxygen as an adjunctive treatment for severe laryngeal necrosis: a report of nine consecutive cases. Undersea Hyperb Med. 1993 Dec;20(4):329-35. |
| ID | Term |
|---|---|
| D011832 | Radiation Injuries |
| D011349 | Proctitis |
| D003556 | Cystitis |
| D004751 | Enteritis |
| D010025 | Osteoradionecrosis |
| ID | Term |
|---|---|
| D014947 | Wounds and Injuries |
| D005759 | Gastroenteritis |
| D005767 | Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |
| D012002 | Rectal Diseases |
| D007410 | Intestinal Diseases |
| D001745 | Urinary Bladder Diseases |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D006931 | Hyperbaric Oxygenation |
| ID | Term |
|---|---|
| D010102 | Oxygen Inhalation Therapy |
| D012138 | Respiratory Therapy |
| D013812 | Therapeutics |
Not provided
Not provided